SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form
8-K
Current
Report
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of
1934
April
4, 2005
Date of
Report
(Date of
earliest event reported)
RITA
Medical Systems, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
(State or
other jurisdiction of incorporation)
000-30959 |
94-3199149 |
|
(Commission
File Number) |
(I.R.S.
Employer Identification No.) |
967
N. Shoreline Blvd.
Mountain
View, CA 94043
(Address
of principal executive offices, with zip code)
(650)
314-3400
(Registrant's
telephone number, including area code)
Item
8.01. Other Events and Required FD Disclosure.
On April
4, 2005, RITA Medical Systems, Inc. (Nasdaq: RITA) announced the introduction of
the StarBurst TALON, a radiofrequency ablation (RFA) device that offers
clinicians the ability to perform fast 4 cm spherical ablations with a novel
side-deploy design that assists precise device positioning in tumors that may be
mobile in soft tissue or adjacent to critical structures. A copy of RITA’s press
release announcing this introduction is attached as Exhibit 99.1 hereto and
incorporated by reference herein.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
|
|
| |
RITA Medical
Systems, Inc. |
|
|
|
| Date: April 4, 2005 |
By: |
/s/ Donald Stewart |
| |
Donald
Stewart, Chief Financial Officer and
Vice
President Finance and Administration |
| |
|
RITA
MEDICAL SYSTEMS, INC.
INDEX
TO EXHIBITS
Exhibit
Number |
Description |
|
| |
|
|
|
99.1 |
Press
Release of RITA Medical Systems, Inc. dated April 5, 2005. |
|